Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+1.69%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$632M
Cap. Flow %
2.82%
Top 10 Hldgs %
31.51%
Holding
1,360
New
72
Increased
666
Reduced
342
Closed
71

Sector Composition

1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMLX icon
1226
Amylyx Pharmaceuticals
AMLX
$875M
$1K ﹤0.01%
266
AMRN
1227
Amarin Corp
AMRN
$305M
$1K ﹤0.01%
67
ANAB icon
1228
AnaptysBio
ANAB
$602M
$1K ﹤0.01%
105
AURA icon
1229
Aura Biosciences
AURA
$391M
$1K ﹤0.01%
+165
New +$1K
SANA icon
1230
Sana Biotechnology
SANA
$729M
$1K ﹤0.01%
767
SLRN
1231
DELISTED
ACELYRIN
SLRN
$1K ﹤0.01%
398
TERN icon
1232
Terns Pharmaceuticals
TERN
$599M
$1K ﹤0.01%
151
TNGX icon
1233
Tango Therapeutics
TNGX
$719M
$1K ﹤0.01%
355
TSHA icon
1234
Taysha Gene Therapies
TSHA
$870M
$1K ﹤0.01%
691
VNDA icon
1235
Vanda Pharmaceuticals
VNDA
$271M
$1K ﹤0.01%
191
VWO icon
1236
Vanguard FTSE Emerging Markets ETF
VWO
$95.9B
$1K ﹤0.01%
30
-25
-45% -$833
VYGR icon
1237
Voyager Therapeutics
VYGR
$209M
$1K ﹤0.01%
201
XERS icon
1238
Xeris Biopharma Holdings
XERS
$1.27B
$1K ﹤0.01%
404
YMAB icon
1239
Y-mAbs Therapeutics
YMAB
$389M
$1K ﹤0.01%
162
ALMS
1240
Alumis Inc. Common Stock
ALMS
$448M
$1K ﹤0.01%
+156
New +$1K
RVNC
1241
DELISTED
Revance Therapeutics, Inc.
RVNC
$1K ﹤0.01%
331
AVIR icon
1242
Atea Pharmaceuticals
AVIR
$266M
$1K ﹤0.01%
242
BCYC
1243
Bicycle Therapeutics
BCYC
$473M
$1K ﹤0.01%
103
CDXS icon
1244
Codexis
CDXS
$212M
$1K ﹤0.01%
+269
New +$1K
EYPT icon
1245
EyePoint Pharmaceuticals
EYPT
$798M
$1K ﹤0.01%
144
GLPG icon
1246
Galapagos
GLPG
$2.04B
$1K ﹤0.01%
51
GLUE icon
1247
Monte Rosa Therapeutics
GLUE
$299M
$1K ﹤0.01%
+203
New +$1K
HCM icon
1248
HUTCHMED
HCM
$2.54B
$1K ﹤0.01%
85
ITOS
1249
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
121
KALV icon
1250
KalVista Pharmaceuticals
KALV
$746M
$1K ﹤0.01%
154